The current study adds to the growing body of evidence by providing a comprehensive, real-world assessment of treatment patterns and outcomes among high-risk patients with T2D and established cardiovascular disease
For wellness professionals, it may eventually become part of a broader longevity toolkit, pending proper validation
This is driven by a multitude of factors including complex and busy lifestyles (e.g., starting a family, education, and employment responsibilities) that may make accessing care in current health-systems difficult [15,112,113]
The main decision now is whether you want a longer commitment or a shorter discounted plan
Ongoing research suggests that GLP-1s may expand into treatments for neurodegenerative conditions, gastrointestinal diseases, liver problems, kidney disease, and more